Idiopathic intracranial hypertension (IIH) is where patients have increased intracranial pressure without an identifiable cause, typically manifesting in headache and other symptoms.
Pathophysiology
- If you break down the name of the condition, IIH involves raised intracranial pressure with no identifiable cause (idiopathic).
- The precise aetiology is still not known but several theories exist on the cause.
- One example is a proposition of transverse venous sinus stenosis. The intracranial venous sinuses are responsible for CSF drainage, so a proposed mechanism is stenosis of the transverse sinus ultimately results in reduced CSF reabsorption and thus higher pressures.
- Other theories do exist such as abnormalities in vitamin A metabolism or the presence of microthrombi in cerebral veins.
Risk Factors
- Female sex and obesity: IIH most commonly affects young, obese women.
- Sleep apnoea
- Polycystic ovarian syndrome
- Association with certain drugs including isotretinoin (Roaccutane), tetraycyclines and nitrofurantoin
Clinical Features
- Headache:
- Usually bilateral
- May be worsened by coughing/sneezing/straining.
- Can be described as being worse in the mornings
- Can be worsened by lying down/bending forward and relieved by standing up
- Pulsatile tinnitus
- Visual disturbances
- Transient vision loss, particularly when bending down
- Bilateral papilledema
- Diplopia
- Decreased visual acuity
- Painful eye movements
- 6th nerve palsy
- Peripheral vision loss
- Pain in the back or neck
Investigations
Based on the clinical history, it is important to rule out any other causes of raised intracranial pressure prior to making a diagnosis of IIH.
Bedside
- History & Examination (Particularly cranial nerves, upper limb neurological and lower limb neurological)
- Fundoscopy: Visualise papilledema
- Lumbar puncture: Typically shows a raised opening pressure (>25cm3) but is otherwise normal. Lumbar punctures may also be therapeutic.
Imaging
- CT or MRI: No obvious lesions should be identified on CT/MRI i.e. by definition; an intracranial mass cannot be responsible for IIH as IIH is characterised by being idiopathic. The empty sella sign may be visualised, which is a flattened pituitary gland, occurring as a result of increased pressure
- CT or MRI venogram: To exclude venous sinus thrombosis
Special Tests
- Visual field testing (Perimetry)
Management
Conservative
- Advise weight reduction – may be able to involve dietetics to facilitate this
Medical
- Acetazolamide: This is a carbonic anhydrase inhibitor. It is an effective drug used to lower intracranial pressure as it reduces CSF production. Can be poorly tolerated due to side effects:
- Paraesthesia, particularly in the extremities
- Tinnitus
- Lethargy
- Altered taste
- Topiramate: Used as an alternative to acetazolamide as it has weak carbonic anhydrase properties.
Surgical
- Lumbo-peritoneal or ventriculo-peritoneal shunting: Shunting CSF into the abdomen either from the lumbar spine or from the ventricle
- Optic nerve sheath fenestration: Creating opening in the sheath of the optic nerve to help relieve pressure from the nerve and protect against visual field loss.
References
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544160/#:~:text=Go%20to%3A-,PATHOPHYSIOLOGY%20OF%20IIH,and%20increased%20cerebral%20venous%20pressure.
https://jnnp.bmj.com/content/89/10/1088
https://www.touchophthalmology.com/neuro-ophthalmology/journal-articles/optic-nerve-sheath-fenestration-indications-and-techniques/
https://www.pacificneuroscienceinstitute.org/hydrocephalus/treatment/shunt-procedures/lumboperitoneal-shunt/
https://www.mskcc.org/cancer-care/patient-education/about-your-ventriculoperitoneal-vp-shunt-surgery